Home › Funds › EVENTIDE ASSET MANAGEMENT, LLC › BBNX
EVENTIDE ASSET MANAGEMENT, LLC position in BBNX
BETA BIONICS INC · Health Care
EVENTIDE ASSET MANAGEMENT, LLC reported holding 7,044,630 shares of BBNX (BETA BIONICS INC) in its Q3 2026 13F filing — a position valued at US$133.7M, representing 1.88% of its reported portfolio and ranking #6 among its reported holdings. EVENTIDE ASSET MANAGEMENT, LLC has disclosed BBNX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How EVENTIDE ASSET MANAGEMENT, LLC's BBNX position evolved
EVENTIDE ASSET MANAGEMENT, LLC first disclosed a stake in BBNX in Q1 2025 at 4,928,019 shares (US$60.3M). The position peaked in Q4 2025 at 4,994,728 shares, worth US$152.2M. Across 7 filings, EVENTIDE ASSET MANAGEMENT, LLC increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 7,044,630 shares valued at US$133.7M — an increase of 790,957 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 4.93M | $60.31M | New |
| Q2 2025 | 4.93M | $71.83M | Hold |
| Q3 2025 | 4.96M | $98.50M | Add |
| Q4 2025 | 4.99M | $152.23M | Add |
| Q1 2026 | 5.95M | $59.57M | Add |
| Q2 2026 | 6.25M | $98.05M | Add |
| Q3 2026 | 7.04M | $133.72M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BBNX and 13F data
BBNX (BETA BIONICS INC) is a Health Care company. 55 other funds we track also report a position in BBNX — the largest reported positions include Sands Capital Alternatives, LLC (US$75.9M), Soleus Capital Management, L.P. (US$68.8M), Vestal Point Capital, LP (US$25.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BBNX
- Sands Capital Alternatives, LLC 4.00M sh · $75.88M · Q3 2026
- Soleus Capital Management, L.P. 4.39M sh · $68.85M · Q2 2026
- Vestal Point Capital, LP 1.60M sh · $25.07M · Q2 2026
- Omega Fund Management, LLC 1.32M sh · $20.62M · Q2 2026
- Eversept Partners, LP 1.25M sh · $19.58M · Q2 2026
- Divisadero Street Capital Management, LP 1.11M sh · $17.45M · Q2 2026
- Bruce & Co., Inc. 665.70K sh · $10.43M · Q2 2026
- Tri Locum Partners LP 493.34K sh · $7.73M · Q2 2026
- PURA VIDA INVESTMENTS, LLC 281.16K sh · $4.41M · Q2 2026
More on EVENTIDE ASSET MANAGEMENT, LLC
FAQ
How long has EVENTIDE ASSET MANAGEMENT, LLC held BBNX?
EVENTIDE ASSET MANAGEMENT, LLC has disclosed BBNX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is EVENTIDE ASSET MANAGEMENT, LLC's current position in BBNX?
As of Q3 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 7.04M shares of BBNX (BETA BIONICS INC), valued at $133.72M, representing 1.88% of its reported portfolio and ranking #6.
Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling BBNX?
In the latest 13F filing (Q3 2026), EVENTIDE ASSET MANAGEMENT, LLC increased its position in BBNX. The position peaked in Q4 2025 at 4.99M shares.
Which other funds hold BBNX?
Other major institutional holders of BBNX include Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Vestal Point Capital, LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.